Registration - In-house Corporation

HOSPIRA HEALTHCARE CORPORATION / CORPORATION DE SOINS DE LA SANTE HOSPIRA / Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand

Registration Information

In-house Corporation name: HOSPIRA HEALTHCARE CORPORATION / CORPORATION DE SOINS DE LA SANTE HOSPIRA
Responsible Officer Name: Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand
Initial registration start date: 2014-01-27
Registration status: Inactive
Registration Number: 887953-329246

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 0

Version 3 of 3 (2015-03-20 to 2015-09-02)

Registration versions:

Version 3 of 3 (2015-03-20 to 2015-09-02)

Lobbying Information

Subject Matters

Consumer Issues
Health
Industry
Intellectual Property
International Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Health Canada with regard to the development and implementation of a framework for Subsequent Entry Biologic (SEB) products
Therapeutic Products Directorate with regard to the Medical Devices Bureau in support of safe and timely access to medical device technologies.

Policies or Program, Regulation

Canada-US Regulatory Cooperation Council with regard to better alignment of regulatory requirements between Canada and the US to streamline regulatory approvals and avoid duplication

Regulation

Health Products and Food Regulatory Modernization with regard to ensuring a modern and efficient regulatory system for drugs and medical devices.

Communication Techniques

Written communication
Oral communication

Government Institutions

Canada Revenue Agency (CRA)
Finance Canada (FIN)
Foreign Affairs, Trade and Development Canada
Health Canada (HC)
House of Commons
Industry Canada
Prime Minister's Office (PMO)
Senate of Canada

In-house Corporation Details

Description of activities

Hospira is the world's leading provider of injectable drugs and infusion technologies. Hospira also has many years of experience in the field of biologics and one of the largest biosimilar pipelines in the industry. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness by improving patient and caregiver safety while reducing healthcare costs.

Responsible officer name and position during the period of this registration

Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
1111 DOCTOR-FREDERIK-PHILIPS BLVD
SUITE 600
SAINT-LAURENT, QC H4M 2X6
Canada

Telephone number: 514-905-2600
Fax number: 514-331-7507

Parent Company Information

HOSPIRA, INC.
- 275 North Field Drive
  Lake Forest, IL 60045
  United States of America

Subsidiary Beneficiary Information

HOSPIRA HEALTHCARE CORPORATION / CORPORATION DE SOINS DE LA SANTE HOSPIRA does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

HOSPIRA HEALTHCARE CORPORATION/CORPORATION DE SOINS DE LA SANTE HOSPIRA

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
HOSPIRA HEALTHCARE CORPORATION/CORPORATION DE SOINS DE LA SANTE HOSPIRA	2014-01-27	2015-09-02

HOSPIRA HEALTHCARE CORPORATION / CORPORATION DE SOINS DE LA SANTE HOSPIRA

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

HOSPIRA HEALTHCARE CORPORATION
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Assistant Deputy Minister | Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry
Communication date: 2014-10-27
Posted date: 2014-11-10
Communication number: 329246-337705 View associated registration
HOSPIRA HEALTHCARE CORPORATION
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Assistant Deputy Minister | Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry
Communication date: 2014-05-05
Posted date: 2014-07-02
Communication number: 329246-329111 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

HOSPIRA HEALTHCARE CORPORATION / CORPORATION DE SOINS DE LA SANTE HOSPIRA / Gerry Stefanatos, Corporate Vice President, President, Canada and Australia/New Zealand

Registration Information

Associated Communications

Version 3 of 3 (2015-03-20 to 2015-09-02)

Version 3 of 3 (2015-03-20 to 2015-09-02)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties